<DOC>
	<DOCNO>NCT00535574</DOCNO>
	<brief_summary>Background : Bexarotene ( Targretin ) synthetic retinoid mainly use treatment patient suffer oncological dermatological disease . The present study base : evidence retinoids involve neurodevelopment ( `` retinoid dysregulation hypothesis '' ) ; assumption combine effect antipsychotic agent bexarotene beneficial effect schizophrenia patient ; positive finding pilot open-label clinical trial ( ClinicalTrials.gov Identifier : NCT00141947 ) . However , clinical efficacy bexarotene investigate placebo-controlled trial . Methods : In 6-week , randomize , double-blind placebo-controlled trial Targretin ( 75 mg/day ) placebo capsule add stable ongoing antipsychotic treatment 90 schizophrenia patient . Participants assess baseline 2 , 4 6 week treatment . A battery research instrument use assessment psychopathology , side effect , general functioning quality life . In addition , cholesterol triglyceride level , liver thyroid function test blood cell count monitor baseline study</brief_summary>
	<brief_title>Bexarotene Augmentation Antipsychotic Treatment Chronic Schizophrenia</brief_title>
	<detailed_description>Recruiting begin November 2008</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Bexarotene</mesh_term>
	<criteria>1 . Age 1860 year , male female 2 . DSMIV criterion schizophrenia , schizoaffective disorder . 3 . Ability willingness sign inform consent participation study 4 . Stable blood parameter include adequate hematologic function , define WBC ≥ 4.300/μL , absolute neutrophil count ≥3.000/μL ( &gt; 50 % ) , platelet count ≥ 180,000/μL ; normal coagulation parameter ; bilirubin ≤1.5 time upper limit normal ( ULN ) ; AST/ALT ≤ 2.5 × ULN ; serum creatinine ≤1.5 mg/dL . 5 . Only patient normal baseline fasting triglyceride ( FTG ) level enter study ; triglyceride may normalize study entry use antilipemic agent . 1 . Lipid abnormality . Fasting triglyceride normal ( normalization antilipemic allow prior study entry ) . 2 . Leucopenia neutropenia . Hematopoietic : Hemoglobin least 12.5 g/dL ; WBC &lt; 4300/μL ; Absolute neutrophil count &lt; 3000/μL ; Platelet count &lt; 155,000/μL 3 . Evidence organic brain damage , mental retardation , alcohol drug abuse 4 . Impairment renal function 5 . Hepatic dysfunction 6 . A history pancreatitis 7 . Thyroid axis alteration 8 . Suicide attempt past year . 9 . Cataracts . 10 . Systemic treatment 15,000 IU vitamin A daily . 11 . Patients know hypersensitivity bexarotene component product . 12 . Pregnant woman woman intend become pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>retinoids</keyword>
	<keyword>bexarotene</keyword>
	<keyword>schizophrenia</keyword>
	<keyword>PANSS</keyword>
	<keyword>Positive negative symptom schizophrenia</keyword>
</DOC>